Search

everythinglearnresearchcommunity

for

Search:↓

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Stem cell treatment improved hair density in female hair loss patient.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Adipose stem cell-derived exosomes greatly improve wound healing.

Lean and obese women with PCOS have similar levels of insulin resistance, indicating it's a core aspect of the condition.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Decanoic acid may help treat PCOS by reducing androgen levels and improving glucose sensitivity.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

Curcumin supplements increase adiponectin and decrease leptin in adults.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

The agouti gene may help understand and treat obesity.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Acne and other skin conditions can indicate internal diseases like Polycystic Ovary Syndrome (PCOS), and early treatment can prevent long-term issues.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Adipose-derived stem cells help heal radiation skin damage by reducing cell death and inflammation.

ADSC-CM treatment improved hair density and thickness in women with hair loss, safely and effectively.

Exosomes from modified stem cells may help treat liver injury.

Adipose tissue and PRP together improve healing and surgery outcomes but need more research for consistent use.

Women with PCOS have higher body fat and skinfold thickness, especially in the H-O-POM phenotype.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

The PHAT technique effectively rejuvenates lips and face.

Syndecan-1 is essential for maintaining skin fat and preventing cold stress.